+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Anergis SA - logo

Anergis SA is a clinical-stage biopharmaceutical company that develops allergy vaccines based on the technology of Contiguous Overlapping Peptides for ultra-fast desensitization. It offers vaccines against birch pollen, ragweed pollen, and house dust mite allergies. Anergis SA was founded in 2001 and is based in Lausanne, Switzerland.

Allergy Immunotherapy Market - Global Forecast 2025-2030 - Product Thumbnail Image

Allergy Immunotherapy Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 182 Pages
  • Global
From
Allergy Immunotherapy Market Report 2025 - Product Thumbnail Image

Allergy Immunotherapy Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Allergy Immunotherapy Market Report and Forecast 2024-2032 - Product Thumbnail Image

Allergy Immunotherapy Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
Birch Pollen Allergy - Pipeline Insight, 2025 - Product Thumbnail Image

Birch Pollen Allergy - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Immunology Collaboration and Licensing Deals 2016-2025 - Product Thumbnail Image

Immunology Collaboration and Licensing Deals 2016-2025

  • Report
  • April 2025
  • 450 Pages
  • Global
From
Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025 - Product Thumbnail Image

Ragweed Pollen Hypersensitivity - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
  • 15 Results (Page 1 of 1)
Loading Indicator